Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW0169 / 1||RA / IM|
Administered by: Public Purchased by: ??
Symptoms: Anxiety, Cough, Heart rate increased
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Other Medications: albuterol inhaler
Current Illness: none reported
Preexisting Conditions: asthma
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: Pt started exhibiting a dry cough that progressed in frequency over the course of aprox. 15 mins. Patients father remained at her side, patients father administered two puffs of patients inhaler, Albuterol, for the coughing. Nurses attended at patients side, checked vitals which were stable with oxygen saturation of 100% and however, pulse noted to be elevated in the 130''s. RN auscultated lung sounds, no wheezing noted, but pt exhibiting signs of anxiousness as well now. Pt assisted to wheelchair and to area to lie down for further evaluation. Pt was lain on her right side, RN remained at her side entire time. Pt advised to use inhaler again, two pufffs, and encouraged to slow her breathing, relax, and was advised that her vitals were stable. Pt was asked if she felt she needed additional support with her breathing and she stated yes. 911 was called and advised of the situation. Pts pulse did lower to 100-105 and breathing did become easier and more regular while we waited for EMS to arrive. Pt transferred to care of EMS with oxygen saturation of 100% and pulse of 104.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166